This Week’s CGT News: New FDA Genome Editing Guidance

Our latest roundup highlights tighter FDA expectations for genome editing safety, advances in CRISPR precision and delivery, and continued momentum for off-the-shelf CAR-T

April 20, 2026
6 min

The Medicine Maker

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI)

Bethesda, MD
Key Differentiators
- Gene Therapy
- Genome Editing
- Hematology
- Immunotherapy
#2

University of Pennsylvania - Abramson Cancer Center

Philadelphia, PA
Key Differentiators
- CAR-T Therapy
- Gene Therapy
- Hematologic Malignancies
#3

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Hematology
- Gene Therapy
- Immunotherapy
#4

Stanford University School of Medicine

Stanford, CA
Key Differentiators
- Genome Editing
- Gene Therapy
- Immuno-oncology
#5

Fred Hutchinson Cancer Center

Seattle, WA
Key Differentiators
- Hematology
- Gene Therapy
- Cell Therapy